SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-000430
Filing Date
2003-02-14
Accepted
2003-02-14 11:55:29
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_021203-alexion.txt SC 13G/A 9888
3 JOINT FILING AGREEMENT ex1-1_021203alexion.txt EX-1.1 2466
4 STATEMENT OF CONTROL PERSON ex2-1_021203alexion.txt EX-2.1 957
  Complete submission text file 0000947871-03-000430.txt   15535
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-47771 | Film No.: 03564231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE